Healthcare Earnings Scoreboard: 96% beat EPS estimates, 70% post Y/Y earnings growth
at seekingalpha.com (Sat, 31-Oct 10:40 AM)
at www.tipranks.com (Fri, 30-Oct 9:10 AM)
Morgan Stanley Keeps Their Sell Rating on Bristol-Myers Squibb (BMY)
at www.tipranks.com (Fri, 30-Oct 9:10 AM)
BMO Capital Remains a Hold on Bristol-Myers Squibb (BMY)
at www.tipranks.com (Fri, 30-Oct 8:08 AM)
Guggenheim Sticks to Their Buy Rating for Bristol-Myers Squibb (BMY)
at www.tipranks.com (Fri, 30-Oct 7:54 AM)
at www.tipranks.com (Fri, 30-Oct 4:55 AM)
Bristol Myers Squibb Sets 8:00 a.m. ET Webcast for Q3 2026 Results as Investors Await Details
Market Chameleon (Thu, 29-Oct 8:09 AM)
Bristol Myers Squibb Earnings Call Highlights Growth Engine
at www.tipranks.com (Thu, 29-Oct 8:11 PM)
4 stocks to watch on Thursday: MSFT, AMZN, DASH, and BMY
at seekingalpha.com (Thu, 29-Oct 8:54 AM)
Bristol Myers Squibb Raises 2026 Outlook on Strong Q3
at www.tipranks.com (Thu, 29-Oct 7:29 AM)
Bristol Myers lifts sales outlook as newer drugs drive growth
at seekingalpha.com (Thu, 29-Oct 7:28 AM)
Bristol Myers Squibb in charts: Legacy revenue rises 1%, while growth portfolio sales jump 12%
at seekingalpha.com (Thu, 29-Oct 7:14 AM)
at seekingalpha.com (Thu, 29-Oct 7:00 AM)
Bristol Myers to bring 12 oral presentations and nearly 60 oncology disclosures to ESMO 2026
Market Chameleon (Mon, 19-Oct 8:50 AM)
Market Chameleon (Mon, 12-Oct 7:30 AM)
Bristol Myers Squibb sets Oct. 29 earnings date with an 8:00 a.m. ET conference call
Market Chameleon (Fri, 18-Sep 7:06 AM)
